The report "Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) - Global Forecast to 2026"
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468
Many approvals for Vascular Closure Devices, high prevalence of cardiovascular disease, increasing prevalence of obesity, increasing market participant interest in large- Vascular Closure Devices, growing geriatric population, favorable reimbursement scenarios for interventional radiation procedures and effective treatments, effective therapeutic surgery Fatal patients are a key factor driving the growth of the Vascular Closure Devices market.
The passive approximators segment is expected to grow at the highest CAGR during the forecast period and accounted for the largest share.
Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market.
North America was the largest regional market for the vascular closure devices market
North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US.
Some prominent players in the global Vascular Closure Devices Market Include:
The global vascular closure devices market is consolidated. The prominent players operating in this market include Terumo Corporation (Japan), Abbott (US), Cardinal Health (US), Cardiva Medical, Inc. (US), Medtronic Plc (Ireland), Morris Innovative, Inc. (US), Teleflex Incorporated (US), Merit Medical Systems, Inc. (US), Vasorum Ltd. (Ireland), TZ Medical, Inc. (US), Vivasure Medical Ltd. (Ireland), Tricol Biomedical (US), Scion Biomedical (US), Advanced Vascular Dynamics (US), Marine Polymer Technologies, Inc. (US), and Rex Medical (US).
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=180101468
MarketsandMarkets analysis show that the global market of vascular closure devices is projected to USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period.
Vascular Closure Devices Market Segmentation
This report categorizes the vascular closure devices market into the following segments and subsegments:
- Passive Approximators
- Collagen Plugs
- Sealant or Gel-based Devices
- Compression Assist Devices
- Active Approximators
- Suture-based Devices
- Clip-based Devices
- External Hemostatic Devices
- Femoral Access
- Radial Access
- Interventional Cardiology
- Interventional Radiology/Vascular Surgery
- North America
- Rest of Europe
- Asia Pacific
- Rest of World